DIPNA PHARMACHEM LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.11 INR | +0.37% |
|
-1.10% | -23.85% |
| Apr. 25 | Dipna Pharmachem Limited announced a financing transaction | CI |
| Apr. 02 | Dipna Pharmachem Bags INR127.5 Million Order for Melamine Powder; Shares Jump 7% | MT |
| Sales 2022 | 728M 8.71M | Sales 2023 | 999M 11.96M | Capitalization | 150M 1.8M |
|---|---|---|---|---|---|
| Net income 2022 | 11M 132K | Net income 2023 | 9M 108K | EV / Sales 2022 * | - |
| Net Debt 2022 | 99.8M 1.19M | Net Debt 2023 | 99.67M 1.19M | EV / Sales 2023 | 0.25 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
16.5
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.47% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.37% | ||
| 1 week | -1.10% | ||
| Current month | -3.80% | ||
| 1 month | -4.14% | ||
| 3 months | -26.94% | ||
| 6 months | -36.39% | ||
| Current year | -23.85% |
1 week
7.90
8.48
1 month
7.519.16
Current year
7.5117.38
1 year
7.5129.35
3 years
7.5133.60
5 years
7.5133.60
10 years
7.5133.60
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-13 | 8.11 | +0.37% | 69 000 |
| 24-06-12 | 8.08 | -1.94% | 216,000 |
| 24-06-11 | 8.24 | +1.35% | 150,000 |
| 24-06-10 | 8.13 | -1.33% | 57,000 |
| 24-06-07 | 8.24 | +0.49% | 69,000 |
Delayed Quote Bombay S.E., June 13, 2024 at 03:29 am EDT
More quotes
Dipna Pharmachem Limited is an India-based trader, importer, and exporter in industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulation. The Company's products include albendazole, ambroxol HCL, amisulpride IP/BP, amoxicillin aripiprazole IP, artemether, azithromycin, cefixime, carbamezapin, calcium gluconate IP, cefadroxyl monohydrate IP/BP/EP cephalexin, clindamycin phosphate IP/BP/USP, clotrimazole, cetrimide powder, chlorhexidine base, chlorhexidine gluconate 20% solution, chlorhexidine hydrochloride, chlorhexidine acetate, dapoxetine HCL, dextromethorphan hydrobromic (DMR), diclofenac potassium, diclofenac sodium, dried alluminiumhydroxide IP, ferric ammounium citrate IP, ferrous ascorbate, folic acid IP, guaiphenesin IP, griseofulvin IP /BP, hydrocortisone acetate, ibuprofen IP, levofloxacin, lumefantrine, lidocaine base, lidocaine hydrochloride, lornoxicam, metronidazole plain/benzoate and mefenamic acid IP.
Sector
Specialty Chemicals
Calendar
2024-11-10
- Q2 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -23.85% | 2.33M | |
| -9.71% | 8.83B | |
| +29.36% | 1.05B | |
| +80.49% | 175M | |
| +31.51% | 139M | |
| -1.13% | 109M | |
| +1.17% | 82.67M |
- Stock Market
- Equities
- DPL Stock
